88
Views
13
CrossRef citations to date
0
Altmetric
Drug Profile

Treatment of chronic hepatitis B: focus on telbivudine

&
Pages 259-268 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Geoffrey M Dusheiko & Michael Graham Jacobs. (2009) Perspectives on the management of chronic hepatitis B and C. Expert Review of Anti-infective Therapy 7:3, pages 243-247.
Read now

Articles from other publishers (12)

Mohammad Rejaur Rahman, Anik Banik, Ishtiak Malique Chowdhury, Emran Hossain Sajib & Sanchita Sarkar. (2021) Identification of potential antivirals against SARS-CoV-2 using virtual screening method. Informatics in Medicine Unlocked 23, pages 100531.
Crossref
Sinara Mônica Vitalino de Almeida, José Cleberson Santos Soares, Keriolaine Lima dos Santos, Josival Emanuel Ferreira Alves, Amélia Galdino Ribeiro, Íris Trindade Tenório Jacob, Cindy Juliane da Silva Ferreira, Jéssica Celerino dos Santos, Jamerson Ferreira de Oliveira, Luiz Bezerra de Carvalho Junior & Maria do Carmo Alves de Lima. (2020) COVID-19 therapy: What weapons do we bring into battle?. Bioorganic & Medicinal Chemistry 28:23, pages 115757.
Crossref
Ma Min, Jiang Xingjun, Wang Xueding, Zou Hao, Yang Weiqing, Zhang Yuanyuan, Peng Changrong, Li Zicheng, Yang Jing, Du Quan & Ma Menglin. (2016) Synthesis and Quantitative Structure-activity Relationships Study for Arylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication. Chemical Biology & Drug Design 88:3, pages 451-459.
Crossref
Jing Yang, Min Ma, Xue-Ding Wang, Xing-Jun Jiang, Yuan-Yuan Zhang, Wei-Qing Yang, Zi-Cheng Li, Xi-Hong Wang, Bin Yang & Meng-Lin Ma. (2015) Synthesis and quantitative structure–activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication. European Journal of Medicinal Chemistry 99, pages 82-91.
Crossref
Chunqiu HaoJiuping WangWenzhen KangYumei XieYun ZhouLi MaMeijuan PengXuefan BaiJianqi LianZhansheng Jia. (2013) Kinetics of Th17 Cytokines During Telbivudine Therapy in Patients With Chronic Hepatitis B. Viral Immunology 26:5, pages 336-342.
Crossref
Angeline Oi-Shan Lo, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Hoi-Yun Chan, Christina Man-Tung Cheung & Henry Lik-Yuen Chan. (2013) Efficacy of Entecavir Switch Therapy in Chronic Hepatitis B Patients with Incomplete Virological Response to Telbivudine. Antiviral Therapy 18:5, pages 671-680.
Crossref
Ye Zhang, Jian-Qi Lian, Yu Li, Jie-Pin Wang, Chang-Xing Huang, Xue-Fan Bai & Jiu-Ping Wang. (2013) Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine. European Journal of Gastroenterology & Hepatology 25:7, pages 814-819.
Crossref
Lai Wei, Shanlian Hu, Jinlin Hou, Gordon Liu, Hong Ren, Zhongping Duan, Qing Xie, Xiao Fang & Jidong Jia. (2013) A Novel Estimation of the Impact of Treatment with Entecavir on Long-Term Mortality, Morbidity, and Health Care Costs of Chronic Hepatitis B in China. Value in Health Regional Issues 2:1, pages 48-56.
Crossref
G. L.‐H. Wong, V. W.‐S. Wong, H.‐Y. Chan, P. C.‐H. Tse, J. Wong, A. M.‐L. Chim, K. K.‐L. Yiu, S. H.‐T. Chu & H. L.‐Y. Chan. (2012) Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HB e A g‐seroconversion in chronic hepatitis B patients at 3 years . Alimentary Pharmacology & Therapeutics 35:11, pages 1326-1335.
Crossref
Peiyuan Wang, Devan Naduthambi, Ralph T. Mosley, Congrong Niu, Phillip A. Furman, Michael J. Otto & Michael J. Sofia. (2011) Phenylpropenamide derivatives: Anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs. Bioorganic & Medicinal Chemistry Letters 21:15, pages 4642-4647.
Crossref
Zhiliang Lv, Chunquan Sheng, Tiantian Wang, Yikai Zhang, Jia Liu, Jilu Feng, Hailing Sun, Hanyu Zhong, Chunjuan Niu & Ke Li. (2009) Design, Synthesis, and Antihepatitis B Virus Activities of Novel 2-Pyridone Derivatives. Journal of Medicinal Chemistry 53:2, pages 660-668.
Crossref
Grace L.-H. Wong & Henry L.-Y. Chan. (2009) Predictors of Treatment Response in Chronic Hepatitis B. Drugs 69:16, pages 2167-2177.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.